Fake medicine yields surprisingly real results for older adults’ memory and stress

Taking a simple sugar pill can boost both the physical and mental health of older adults, even when they know the pill contains no active medicine. Research published in the International Journal of Clinical and Health Psychology shows that these transparently fake treatments can reduce stress and elevate short-term memory just as well as pills given under deception. These results point toward a highly ethical and side-effect-free way to help aging populations maintain their everyday capabilities.

Medical science frequently relies on the placebo effect to understand how new drugs work. A placebo is an inactive substance, such as a sugar pill or a saline injection. In typical clinical trials, researchers give some people the real medicine and others a placebo without telling them which one they received. The mere expectation of getting better often causes a real physical or psychological improvement in the patient.

For many years, doctors assumed that patients had to believe they were taking real medicine for a placebo to work. Deception seemed like a mandatory requirement for the mind to trigger the body’s internal healing responses. Recent studies have challenged that old assumption by testing entirely transparent treatments. Medical researchers refer to these transparent treatments as open-label placebos.

When a doctor hands a patient an open-label placebo, they clearly explain that the pill has no active medical ingredients. The doctor also explains that the human brain can still produce a healing response just by going through the familiar motions of taking daily medicine. Acknowledging this mind-body connection can activate automatic biological responses that improve a patient’s symptoms.

Prior tests of open-label placebos have mostly focused on specific medical conditions, like chronic joint pain or irritable bowel syndrome. Few researchers have looked at how these transparent pills might affect the natural physical and mental changes that come with getting older. Aging is heavily influenced by a person’s individual expectations and mindset. People who hold negative stereotypes about aging tend to experience much faster declines in their general health.

Diletta Barbiani, a psychology researcher at the Università Cattolica del Sacro Cuore in Milan, Italy, led a new investigation to see if transparent placebos could alter typical aging patterns. Barbiani worked with psychology professors Alessandro Antonietti and Francesco Pagnini, who are also based at the Università Cattolica. The research team wanted to see if an inactive pill could improve memory, attention, and physical mobility in older adults without relying on any form of deception.

Pagnini noted in a press release that the project fits into a broader scientific mission. “The study is part of an established line of research in which we analyze the role of the mind in aging processes, which is very important,” Pagnini said. The researchers designed a trial to see exactly how these mind-body connections manifest in older adults.

To test this idea, Barbiani and her colleagues recruited ninety healthy adults between the ages of 65 and 90 living in the community. They randomly divided these volunteers into three groups of thirty people each. The first group served as a control group and received no pills at all.

The researchers gave the second group a three-week supply of pills but used a classic deceptive approach. They told these participants that the pills were a daily multivitamin formulated specifically to boost cognitive abilities, reduce fatigue, and lower stress. The pills were entirely inactive, but the participants believed they were taking a helpful supplement.

The third group received the exact same inactive pills, but the researchers used an honest, open-label approach. They explicitly told these participants that the tablets were simply sugar pills with no therapeutic properties whatsoever. Along with the truth, the researchers gave this group a brief explanation of how the placebo effect works.

The team explained that taking a pill can act as a powerful psychological trigger. They compared it to the classical conditioning experiments of Ivan Pavlov, where dogs learned to salivate at the sound of a bell because they associated the sound with food. In the same way, the researchers explained, the daily ritual of taking a pill can train the human body to automatically release chemical responses that improve well-being.

All participants took a battery of tests before the three-week period began and again after it ended. The researchers measured subjective feelings using questionnaires about perceived stress, daytime sleepiness, and overall life satisfaction. They also measured objective skills using memory tests, attention tasks, and physical mobility exercises. The physical tests included measuring walking speed, standing balance, and the ability to stand up from a chair repeatedly.

To measure short-term working memory, the researchers used a number-recall test. The experimenter read a sequence of digits aloud, and the participant had to repeat them back in the exact same order or in reverse. To test selective attention, the participants completed a color-word task. They had to name the ink color of a printed word while ignoring the actual word itself, which was often the name of a different color.

At the end of the three weeks, the group that knowingly took the sugar pills reported a measurable drop in their stress levels. Their perceived stress scores were notably lower than both the control group and the group that took the deceptive placebo. The honest approach seemed to offer the absolute best relief for daily emotional tension.

The open-label placebo group also performed better on objective tests of short-term memory. When asked to remember and repeat the sequences of numbers, the participants who knew they were taking a placebo scored higher than the control group. Both groups taking pills showed clear improvements from their own starting scores on attention and physical performance tasks.

The objective improvements were quite pronounced across the board. The group that knew they were taking a placebo showed improved physical test scores and a noticeable jump in memory capacity. The deceptive placebo group also saw physical and cognitive gains, though the transparent group showed particularly strong effects. These results suggest that deception is not a strict requirement for older adults to experience the benefits of a placebo.

Being honest and explaining the underlying science seemed to foster a strong sense of trust between the researchers and the participants. The participants who knew the truth may have felt more engaged in the experimental process, which could have amplified their bodily response. A transparent explanation might give patients a greater sense of agency over their own health outcomes.

While the results show great promise, the researchers acknowledged several limitations to their experimental design. The sample size of ninety people was relatively small. A larger group of participants would be necessary to confirm these patterns and ensure the outcomes were consistent across different demographics. The small sample size might also explain why the differences between the groups were not statistically significant for other psychological measures, like optimism or daytime sleepiness.

The short time frame of the study also leaves several unanswered questions. The participants only took the pills for three weeks, which is a very brief window to track changes in aging. It remains unclear whether the benefits to memory, stress, and physical mobility would last over several months or years of taking an open-label placebo.

The researchers also noted that they did not conduct a formal medical screening for dementia or other cognitive impairments before the trial began. All participants appeared healthy and understood the instructions during the trial. However, standardized cognitive tests would help future researchers understand exactly who benefits most from these inactive treatments.

The team also hopes to track biological markers in future trials. Measuring heart rate, brain waves, or stress hormones like cortisol could reveal exactly how the body translates a known fake pill into a real physical benefit. Right now, the exact physiological pathways remain largely theoretical.

Despite these limitations, the concept of open-label placebos offers an exciting new tool for geriatric care. Doctors often face a dilemma when they suspect a patient might benefit from a placebo. Lying to patients violates ethical standards of medical transparency. The success of open-label placebos provides an ethical way out of this trap.

In the future, healthcare providers might prescribe a simple, honest placebo alongside standard treatments to help older adults manage the natural declines of aging. By harnessing the power of the mind in a completely transparent way, older adults could potentially improve their physical and mental independence. This approach offers a potential treatment that costs very little and has absolutely zero side effects.

The study, “Placebo mechanisms in aging: A randomized controlled trial comparing deceptive and open-label placebos on psychological, cognitive, and physical functioning in older adults,” was authored by Diletta Barbiani, Alessandro Antonietti, and Francesco Pagnini.